A detailed history of Dimensional Fund Advisors LP transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,346,493 shares of ORGO stock, worth $9.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,346,493
Previous 2,036,743 15.21%
Holding current value
$9.06 Million
Previous $5.7 Million 17.68%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$2.42 - $3.24 $749,595 - $1 Million
309,750 Added 15.21%
2,346,493 $6.71 Million
Q2 2024

Aug 09, 2024

BUY
$2.28 - $3.03 $759,520 - $1.01 Million
333,123 Added 19.55%
2,036,743 $5.7 Million
Q1 2024

May 10, 2024

BUY
$2.61 - $4.49 $826,012 - $1.42 Million
316,480 Added 22.82%
1,703,620 $4.84 Million
Q4 2023

Feb 07, 2024

BUY
$1.97 - $4.21 $1.05 Million - $2.23 Million
530,620 Added 61.95%
1,387,140 $5.67 Million
Q3 2023

Nov 09, 2023

BUY
$2.34 - $4.43 $1.03 Million - $1.95 Million
441,173 Added 106.22%
856,520 $2.72 Million
Q2 2023

Aug 09, 2023

SELL
$1.9 - $4.3 $76,433 - $172,980
-40,228 Reduced 8.83%
415,347 $1.38 Million
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $131,623 - $204,051
-69,642 Reduced 13.26%
455,575 $970,000
Q4 2022

Feb 09, 2023

SELL
$2.48 - $3.43 $521,370 - $721,088
-210,230 Reduced 28.59%
525,217 $1.41 Million
Q3 2022

Nov 10, 2022

SELL
$3.14 - $6.43 $228,400 - $467,711
-72,739 Reduced 9.0%
735,447 $2.38 Million
Q2 2022

Aug 12, 2022

BUY
$4.74 - $8.15 $2.95 Million - $5.07 Million
622,589 Added 335.45%
808,186 $3.94 Million
Q1 2022

May 13, 2022

BUY
$6.47 - $9.57 $32,427 - $47,964
5,012 Added 2.78%
185,597 $1.41 Million
Q4 2021

Feb 09, 2022

BUY
$9.02 - $13.5 $412,168 - $616,882
45,695 Added 33.88%
180,585 $1.67 Million
Q3 2021

Nov 12, 2021

BUY
$13.71 - $17.18 $1.85 Million - $2.32 Million
134,890 New
134,890 $1.92 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.